Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Braakhuis BJ, Kegel A, Welters MJ (1994) The growth inhibiting effect of docetaxel (Taxotere) in head and neck squamous cell carcinoma xenografts. Cancer Lett 81: 151–154
2. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338: 1798–1804
3. Budach W, Hehr T, Belka C, Bamberg M (2000) Alternating chemo-radiation with docetaxel (D)/cisplatin (C) and involved field radiotherapy for recurrent, inoperable, and previously irradiated head and neck cancer (HNC). Proc Am Soc Clin Oncol 19: 1649
4. Caponigro F, Massa E, Manzione L, Rosati G, Biglietto M, De Lucia L, Sguotti C, Sganga P, Avallone A, Comella P, Mantovani G, Comella G (2001) Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG). Ann Oncol 12: 199–202
5. Catimel G, Verweij J, Mattijssen V, Hanauske A, Piccart M, Wanders J, Franklin H, Le Bail N, Clavel M, Kaye SB (1994) Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Ann Oncol 5: 533–537
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献